Organometallics
Organometallic compounds are those that contain bonds between carbon atoms and metals, usually transition metals such as magnesium, zinc, or platinum. These compounds exhibit a wide structural and chemical diversity, giving them high reactivity. They are mainly used in organic synthesis, catalysing reactions such as monomer polymerisation and carbon-carbon bond formation. Additionally, organometallic compounds have applications in the pharmaceutical industry, including the manufacture of anticancer drugs, as well as in industrial processes such as plastic and fuel production.
At CymitQuimica, we offer a wide range of organometallic compounds for research in organic chemistry, catalysis, and the synthesis of new materials.
Found 4396 products of "Organometallics"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Deferitrin
CAS:<p>Deferitrin (GT-56-252) is an iron chelator. It potentially for the treatment of thalassemia and iron overload.</p>Formula:C11H11NO4SPurity:98.71%Color and Shape:SolidMolecular weight:253.27Bismuth Potassium Citrate-d8 (Bismuth Subcitrate-d8)
CAS:Formula:C6H4D4O7·Bi·3KMolecular weight:2*196.15 208.98 3*39.10DOTE (di-n-Octyltin bis(2-ethylhexyl) mercaptoacetate)-d4
CAS:Formula:C36H68O4S2SnD4Molecular weight:755.81PHD-1-IN-1
CAS:<p>PHD-1-IN-1 is a potent inhibitor of hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme(IC50 = 0.034 μM).</p>Formula:C13H8N4Purity:99.74%Color and Shape:SolidMolecular weight:220.23Gastrodenol
CAS:<p>Gastrodenol (Bismuth tripotassium dicitrate) is a bismuth compound used for peptic ulcer and gastro-oesophageal reflux disease.</p>Formula:C12H10BiK3O14Purity:98% - 98.39%Color and Shape:SolidMolecular weight:704.47BISMUTH SUBGALLATE
CAS:<p>Bismuth subgallate (Dermatol Puder) is an astringent and antiseptic and is applied to skin diseases such as eczema.</p>Formula:C7H5BiO6Purity:98.7%Color and Shape:White To Yellow CrystalsMolecular weight:394.09Gadoteric Acid
CAS:Controlled Product<p>Applications Gadoteric Acid is used for magnetic resonance imaging.<br>References Gheuens, E., et al.: Invest. Radiol., 49, 505-508 (2014)<br></p>Formula:C16H25GdN4O8Color and Shape:White To Off-WhiteMolecular weight:558.64(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:319.1199951171875Oxaliplatin
CAS:Controlled Product<p>Applications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H14N2O4PtColor and Shape:White To Off-WhiteMolecular weight:397.295-Amino-2,4,6-triiodoisophthalic Acid
CAS:Controlled Product<p>Impurity Iohexol EP Impurity K<br>Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.<br></p>Formula:C8H4I3NO4Color and Shape:NeatMolecular weight:558.84Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate
CAS:Controlled Product<p>Impurity Oxaliplatin EP Impurity E<br>Stability Light Sensitive<br>Applications A dimeric impurity of Oxaliplatin (O845075) with neoplasm-inhibiting activity.<br>References Gill, D.: Dev. Oncol., 17, 267 (1984);<br></p>Formula:C12H30N6O8Pt2Color and Shape:White To Light YellowMolecular weight:776.5613-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid
CAS:<p>Applications 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid is an impurity in the synthesis of Gadoteridol, an MRI contrast chelating agent.<br>References Petersein, J. et al.: Am. J. Roentgenol., 165, 1167 (1995);<br></p>Formula:C13H22N4O5Color and Shape:White SolidMolecular weight:314.34Iohexol
CAS:Controlled Product<p>Applications Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H26I3N3O9Color and Shape:Off-WhiteMolecular weight:821.14N-Acetyl Cyclized Iodixanol
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications N-Acetyl Cyclized Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C35H43I5N6O15Color and Shape:NeatMolecular weight:1422.27Gadodiamide
CAS:Controlled Product<p>Applications Gadodiamide is an apoptosis inducing agent used in chondrocytes. It is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001);<br></p>Formula:C16H26GdN5O8Color and Shape:NeatMolecular weight:573.66(3-(Piperidin-1-yl)phenyl)boronic acid
CAS:Formula:C11H16BNO2Purity:97%Color and Shape:SolidMolecular weight:205.06DOTA
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.<br>References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),<br></p>Formula:C16H28N4O8Color and Shape:Light YellowMolecular weight:404.42N,N’-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Impurity Iohexol USP Related Compound C<br>Applications N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide is used in the preparation of X-ray contrast agents.<br>References Haavaldsen, J. et al.: Acta Pharmac. Sue., 20, 219 (1983);<br></p>Formula:C14H19N3O8Color and Shape:White To Off-WhiteMolecular weight:357.32Dihydroxy Oxaliplatin-Pt(IV)
CAS:Controlled Product<p>Applications An Oxaliplatin (O845075) derivative. An orally active antitumor cyclohexanediamine-Pt(IV) complex. Oxaliplatin impurity C as per EP.<br>References Yamashita, T., et al.: Biol. Pharma. Bull., 16, 1014 (1993),<br></p>Formula:C8H16N2O6PtColor and Shape:White To Light YellowMolecular weight:431.30Potassium Trichloroammineplatinate
CAS:Controlled Product<p>Applications Potassium Trichloroammineplatinate is the degradation product of Cisplatin (C499500), an antitumor compound which exhibits mutagenic activity.<br>References Peer, R.L., et al.: Enivron. Mutagen., 3, 555 (1981); Macquet, J.P., et al.: Develop. Oncol., 17, 27 (1984); Macquet, J.P., et al.: J. Clin. Hematol. Oncol., 7, 469 (1997);<br></p>Formula:K·Cl3H3NPtColor and Shape:NeatMolecular weight:357.57Caldiamide Sodium
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Caldiamide Sodium is an analog of Gadodiamide (G125710) which is an apoptosis inducing agent used in chondrocytes. Gadodiamide is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001)<br></p>Formula:C16H26CaN5NaO8Color and Shape:NeatMolecular weight:479.48Cyclic Iodixanol (90%)
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Cyclic Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C33H41I5N6O14Purity:90%Color and Shape:NeatMolecular weight:1380.23Transplatin
CAS:<p>Applications Transplatin is the trans stereoisomer impurity of Cisplatin (C499500), an antineoplastic used in the treatment of sarcomas, some carcinomas, lymphomas, and germ cell tumors. Transplatin binds to DNA but does not exhibit the same useful pharmacological effect as its cis stereoisomer.<br>References Cersosimo, R.J.: Cancer Treat. Rev., 16, 195 (1989); Takeiri, A. et al.: Genes Environ., 29, 89 (2007); Giraud-Panis, M.-J. et al.: Pharmacol. Therap., 85, 175 (2000);<br></p>Formula:Cl2H6N2PtColor and Shape:Light YellowMolecular weight:300.04(2-Butoxy-4-fluorophenyl)boronic acid
CAS:Formula:C10H14BFO3Purity:95.0%Color and Shape:SolidMolecular weight:212.03Iohexol-D5
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Deuterated Iohexol. Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H21D5I3N3O9Color and Shape:NeatMolecular weight:826.17(2-Ethoxy-4-methylpyridin-3-yl)boronic acid
CAS:Purity:95+%Color and Shape:SolidMolecular weight:181.01,1-Cyclobutanedicarboxylic Acid
CAS:<p>Applications 1,1-Cyclobutanedicarboxylic Acid is used in the design, studies and structural model of antitumor dicycloplatin a clinical cancer drug. Hydrolysis mechanism of second-generation anticancer drug carboplatin.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Yang, X. Q., et al.: Science China: Chemistry, 53, 1346 (2010); Pavelka, M., et al.: Chem. Eur. J., 13, 10108 (2007)<br></p>Formula:C6H8O4Color and Shape:NeatMolecular weight:144.133-(Methoxycarbonyl)thiophene-2-boronic acid
CAS:Purity:95%Color and Shape:SolidMolecular weight:185.99000549316406{1-[(tert-Butoxy)carbonyl]-1,2,5,6-tetrahydropyridin-3-yl}boronic acid
CAS:Purity:98%Molecular weight:227.0700073N1-(2-(2,3-Dihydroxypropoxy)-3-hydroxypropyl Iohexol
CAS:<p>Impurity Iohexol EP Impurity E<br>Applications N1-(2-(2,3-dihydroxypropoxy)-3-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C22H32I3N3O11Color and Shape:NeatMolecular weight:895.22(3-Chloro-5-propoxyphenyl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:214.4499969482422(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
CAS:Formula:C10H16BNO4SPurity:98%Molecular weight:257.111,1'-Bis{(S)-4,5-dihydro-3H-binaphtho[1,2-c:2',1'-e]phosphino}ferrocene, min. 98% (S,S)-f-Binaphane
CAS:<p>1,1'-Bis{(S)-4,5-dihydro-3H-binaphtho[1,2-c:2',1'-e]phosphino}ferrocene, min. 98% (S,S)-f-Binaphane</p>Formula:C54H40FeP2Purity:min. 98%Color and Shape:yellow-brown pwdr.Molecular weight:806.69(5,6-Difluoropyridin-3-yl)boronic acid
CAS:Formula:C5H4BF2NO2Purity:96%Color and Shape:No data available.Molecular weight:158.9(4-((2-Isopropyl-5-methylphenoxy)methyl)phenyl)boronic acid
CAS:Purity:96%Molecular weight:284.1600036621094Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Formula:C6H12N2O4PtColor and Shape:White To Off-WhiteMolecular weight:371.25Des(2-Hydroxypropyl) Gadoteridol
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Des(2-hydroxypropyl) Gadoteridol is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent.<br>References Filippi, M. et al.: Chem. Comm., 50, 3453 (2014); Ferrauto, G. et al.: J. Am. Chem. Soc., 136, 638 (2014);<br></p>Formula:C14H23GdN4O6Color and Shape:NeatMolecular weight:500.613-Chloro-4-pyridineboronic acid hydrate
CAS:Formula:C5H7BClNO3Purity:95.0%Color and Shape:SolidMolecular weight:175.385-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An intermediate used in the synthesis of imaging agents such as Iohexol (I729500).<br>References Priebe, H., et al.: J. Clin. Pharm. Ther., 24, 227 (1999),<br></p>Formula:C16H20I3N3O7Color and Shape:NeatMolecular weight:747.062-Fluoro-3-methoxyphenylboronic acid
CAS:Controlled Product<p>Applications 2-Fluoro-3-methoxyphenylboronic acid<br></p>Formula:C7H8BFO3Color and Shape:NeatMolecular weight:169.95Oxaliplatin-d10
CAS:Controlled Product<p>Applications Oxaliplatin-d10, is the labeled analogue of Oxaliplatin (O845075), which is platinum-based antineoplastic agent that is used in cancer chemotherapy.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H4D10N2O4PtColor and Shape:NeatMolecular weight:407.35Bis(N,N'-di-t-butylacetamidinato)iron (II), min. 98%
CAS:<p>Bis(N,N'-di-t-butylacetamidinato)iron (II), min. 98%</p>Formula:C20H42N4FePurity:min. 98%Color and Shape:dark gray solidMolecular weight:394.42(5-Cyano-1H-indol-2-yl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:185.97999572753906(4-(Decyloxy)phenyl)boronic acid
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:278.20001220703125(1-(Tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)boronic acid
CAS:Purity:98%Molecular weight:181.99000549316406Cyclooctatetraene iron tricarbonyl, 98%
CAS:<p>Cyclooctatetraene iron tricarbonyl, 98%</p>Formula:C8H8Fe(CO)3Purity:98%Color and Shape:red to brown xtl.Molecular weight:244.03(4-Chloro-2-propoxyphenyl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:214.44999694824225-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Used as an intermediate in the industrial preparation of non-ionic X-ray contrast agents such as Iohexol (I729500), Ioversol (I737000), Ioxilan (I737500), Iopamidol (I735600).<br>References Rongved, P., et al.: Carbohydrate Res., 297, 325 (1997),<br></p>Formula:C14H18I3N3O6Color and Shape:NeatMolecular weight:705.02(3-((4-Chlorophenoxy)methyl)phenyl)boronic acid
CAS:Formula:C13H12BClO3Purity:95.0%Color and Shape:SolidMolecular weight:262.5(4-(Diisopropylcarbamoyl)-2-ethoxypyridin-3-yl)boronic acid
CAS:Purity:95+%Molecular weight:294.16000366210944-Borono-2,6-difluorobenzoic acid
CAS:Formula:C7H5BF2O4Purity:98%Color and Shape:No data available.Molecular weight:201.92[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum
CAS:<p>Applications [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN')diiodoplatinum is a potential antitumor agent. Impurity of Oxiplatin (O845075), third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y. et al.: Biomed. Pharmacther., 43, 261 (1989); Noji, M. et al.: J. Med. Chem., 24, 508 (1981); Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C6H14I2N2PtColor and Shape:NeatMolecular weight:563.08(3-Methoxypyridin-4-yl)boronic acid hydrate
CAS:Formula:C6H10BNO4Purity:95.0%Color and Shape:SolidMolecular weight:170.96(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid
CAS:Purity:98%Molecular weight:252.10000610351562N1-(3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl) Iohexol
CAS:Controlled Product<p>Impurity Iohexol EP Impurity D<br>Applications N1-(3-(2,3-dihydroxypropoxy)-2-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C22H32I3N3O11Color and Shape:Off-WhiteMolecular weight:895.22
![Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD416765.webp&w=3840&q=75)
![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT283945.webp&w=3840&q=75)
![{1-[(tert-Butoxy)carbonyl]-1,2,5,6-tetrahydropyridin-3-yl}boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF625887.webp&w=3840&q=75)
![1,1'-Bis{(S)-4,5-dihydro-3H-binaphtho[1,2-c:2',1'-e]phosphino}ferrocene, min. 98% (S,S)-f-Binapha…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F08%2Fthumb-webp%2F26-0243.webp&w=3840&q=75)
![[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC984525.webp&w=3840&q=75)
